Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

Research Institute of the McGill University Health Centre

$476,333.00

Impact of COVID-19 on Patients Receiving Hemodialysis: The Quebec Renal Network (QRN) COVID-19 Study

FY 2020-21

Summary
There are 24,000 Canadians living with kidney failure who must receive regular hemodialysis treatments to stay alive. This involves coming to the dialysis unit 3 days every week, for 4-5 hours at a time. While this is burdensome at the best of times, the COVID-19 pandemic has made life even more difficult for hemodialysis patients. As they cannot self-isolate, they are at higher risk of infection than others. If they do get infected, this may not be easily identified because they may not have typical symptoms or may deny them for fear of being denied dialysis. Yet, due to their underlying medical illnesses, dialysis patients are at risk of becoming quite ill from COVID-19. The precise risks to their health are uncertain. Finally, widespread application of infection control measures in dialysis units and physical distancing, while needed to control spread of COVID-19, may have unforeseen impacts on all hemodialysis patients. These range from encountering problems with transportation, interfering with their critical need to get to the dialysis unit, to their interactions with the health care team, access to non-dialysis health care, and inability to have their loved ones at their bedside during dialysis. Being the province hardest hit with COVID-19, we have established a province-wide team of kidney doctors and other experts in Quebec to study: (1) the infection control measures implemented in each dialysis unit; (2) how to better identify dialysis patients who have COVID-19; (3) their risk of dying from COVID-19 and the longer-term risk of COVID-19 on their physical and mental health; (4) whether they develop antibodies to this infection; and (5) how all dialysis patients have generally been affected by this pandemic with respect to dialysis and non-dialysis medical care. The results of this comprehensive study will guide our understanding of the impact of COVID-19 on dialysis patients in order to help improve their care both in Canada and globally.
Program
Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
430072
Name
Suri Rita
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
COVID-19 Rapid Research - Clinical Management & Health System Interventions
Projecttitle
Impact of COVID-19 on Patients Receiving Hemodialysis: The Quebec Renal Network (QRN) COVID-19 Study
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$476,333
Cihrequipment2
$0
Programname2
Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions
Keyworddelim
Covid-19; Health Outcomes; Hemodialysis; Hospitalisation; Infection Prevention And Control; Mortality; Observational Study; Pandemic; Patient-Reported Outcome Measures; Qualitative Study
Abstract
There are 24,000 Canadians living with kidney failure who must receive regular hemodialysis treatments to stay alive. This involves coming to the dialysis unit 3 days every week, for 4-5 hours at a time. While this is burdensome at the best of times, the COVID-19 pandemic has made life even more difficult for hemodialysis patients. As they cannot self-isolate, they are at higher risk of infection than others. If they do get infected, this may not be easily identified because they may not have typical symptoms or may deny them for fear of being denied dialysis. Yet, due to their underlying medical illnesses, dialysis patients are at risk of becoming quite ill from COVID-19. The precise risks to their health are uncertain. Finally, widespread application of infection control measures in dialysis units and physical distancing, while needed to control spread of COVID-19, may have unforeseen impacts on all hemodialysis patients. These range from encountering problems with transportation, interfering with their critical need to get to the dialysis unit, to their interactions with the health care team, access to non-dialysis health care, and inability to have their loved ones at their bedside during dialysis. Being the province hardest hit with COVID-19, we have established a province-wide team of kidney doctors and other experts in Quebec to study: (1) the infection control measures implemented in each dialysis unit; (2) how to better identify dialysis patients who have COVID-19; (3) their risk of dying from COVID-19 and the longer-term risk of COVID-19 on their physical and mental health; (4) whether they develop antibodies to this infection; and (5) how all dialysis patients have generally been affected by this pandemic with respect to dialysis and non-dialysis medical care. The results of this comprehensive study will guide our understanding of the impact of COVID-19 on dialysis patients in order to help improve their care both in Canada and globally.
Competitiondate
202005
Approvedterm2
1 yr 0 mth
Pinamesdelim
Suri, Rita; Beaubien-Souligny, William; Nadeau-Fredette, Annie-Claire
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $476,333~ $0~
Research Institute of the McGill University Health Ce… | Canada Spends